Healthcare · Hospital/Nursing Management
HCHCA Healthcare Inc
$506.92 +0.88 (+0.17%) Pre-market $506.00 (-0.01%) ≈ ₹47,575 a share
Key numbers
- Market value
- $105.89B
- P/E (TTM)
- 16.8
- Forward P/E
- 17.0
- EPS (TTM)
- $30.19
- Dividend yield
- 0.62%
- Beta
- 1.10
- Day range
- $503.20 – $512.18
- 52-week range
- $353.99 – $556.52
- Volume
- 151,628
- 10-day avg volume
- $1.46M
- Revenue (TTM)
- $78.70B
- EBITDA (TTM)
- $15.79B
- Gross margin
- 85.3%
- Net margin
- 9.9%
- Return on equity
- —
- Debt / equity
- -625.2%
- Price / sales
- 1.35
- Shares out
- 208.89M
Quarterly results
Results for each quarter
Last 12 quarters from 10-Q and 10-K filings with the US SEC. Q4 = full year minus the first three quarters. Hover a bar to see the number.
Revenue and net income
Revenue · QoQ (vs last quarter)
Revenue · YoY (vs a year ago)
Net income · QoQ (vs last quarter)
Net income · YoY (vs a year ago)
| US$ | Dec 23 | Mar 24 | Jun 24 | Sep 24 | Dec 24 | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Sep 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.30B | $17.34B | $17.49B | $17.49B | $18.29B | $18.32B | $18.61B | $19.16B | $19.51B | $19.11B | $20.23B | $19.85B |
| Interest expense | $491.00M | $512.00M | $506.00M | $515.00M | $528.00M | $547.00M | $568.00M | $561.00M | $572.00M | $584.00M | $599.00M | $607.00M |
| Pre-tax income | $2.35B | $2.25B | $2.24B | $1.91B | $2.13B | $2.33B | $2.42B | $2.42B | $2.67B | $2.29B | $2.49B | $2.37B |
| Income tax | $484.00M | $445.00M | $550.00M | $424.00M | $447.00M | $502.00M | $524.00M | $515.00M | $509.00M | $430.00M | $564.00M | $521.00M |
| Net income | $1.61B | $1.59B | $1.46B | $1.27B | $1.44B | $1.61B | $1.65B | $1.64B | $1.88B | $1.62B | $1.70B | $1.58B |
| Net margin | 9.3% | 9.2% | 8.4% | 7.3% | 7.9% | 8.8% | 8.9% | 8.6% | 9.6% | 8.5% | 8.4% | 8.0% |
| EPS (diluted) | — | $5.93 | $5.53 | $4.88 | — | $6.45 | $6.83 | $6.96 | — | $7.15 | $7.62 | $7.27 |
Income statement
Results for each year
8 fiscal years from the company's 10-K filings with the US SEC.
Revenue, gross profit and net income
Revenue · YoY (vs a year ago)
Net income · YoY (vs a year ago)
EPS (diluted) · YoY (vs a year ago)
| US$ | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $46.68B | $51.34B | $51.53B | $58.75B | $60.23B | $64.97B | $70.60B | $75.60B |
| Revenue growth | — | 10.0% | 0.4% | 14.0% | 2.5% | 7.9% | 8.7% | 7.1% |
| Depreciation & amortisation | $2.28B | $2.60B | $2.72B | $2.85B | $2.97B | $3.08B | $3.31B | $3.52B |
| Interest expense | $1.76B | $1.82B | $1.58B | $1.57B | $1.74B | $1.94B | $2.06B | $2.25B |
| Pre-tax income | $5.34B | $5.24B | $5.43B | $9.83B | $8.58B | $7.71B | $8.52B | $9.83B |
| Income tax | $946.00M | $1.10B | $1.04B | $2.11B | $1.75B | $1.62B | $1.87B | $2.05B |
| Tax rate | 17.7% | 21.0% | 19.2% | 21.5% | 20.3% | 21.0% | 21.9% | 20.9% |
| Net income | $3.79B | $3.51B | $3.75B | $6.96B | $5.64B | $5.24B | $5.76B | $6.78B |
| Net margin | 8.1% | 6.8% | 7.3% | 11.8% | 9.4% | 8.1% | 8.2% | 9.0% |
| EPS (diluted) | $10.66 | $10.07 | $10.93 | $21.16 | $19.15 | $18.97 | $22.00 | $28.33 |
Balance sheet
Assets and debt
At each fiscal year end.
Equity, debt and cash
Shareholders' equity · YoY (vs a year ago)
| US$ | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $502.00M | $621.00M | $1.79B | $1.45B | $908.00M | $935.00M | $1.93B | $1.04B |
| Short-term investments | — | — | $116.00M | $103.00M | — | — | — | — |
| Current assets | $10.21B | $11.20B | $12.33B | $13.54B | $13.64B | $14.93B | $16.41B | $15.78B |
| Total assets | $39.21B | $45.06B | $47.49B | $50.74B | $52.44B | $56.21B | $59.51B | $60.72B |
| Current liabilities | $7.57B | $7.76B | $8.70B | $9.58B | $9.90B | $12.66B | $15.18B | $16.35B |
| Long-term debt | $32.03B | $33.58B | $30.80B | $34.34B | $37.71B | $37.17B | $38.33B | $41.60B |
| Short-term debt | $788.00M | $145.00M | $209.00M | $237.00M | $370.00M | $2.42B | $4.70B | $4.89B |
| Total debt | $32.82B | $33.72B | $31.00B | $34.58B | $38.08B | $39.59B | $43.03B | $46.49B |
| Total liabilities | $42.13B | $45.62B | — | — | — | — | — | — |
| Shareholders' equity | $-4.95B | $-2.81B | $572.00M | $-933.00M | $-2.77B | $-1.77B | $-2.50B | $-6.03B |
| Current ratio | 1.35 | 1.44 | 1.42 | 1.41 | 1.38 | 1.18 | 1.08 | 0.97 |
| Debt / equity | — | — | 54.20 | — | — | — | — | — |
| Return on equity | — | — | 656.3% | — | — | — | — | — |
Cash flow
Cash coming in and going out
Free cash flow = cash from operations minus capital spending. Shareholder returns = dividends + buybacks.
Free cash flow and shareholder returns
Operating cash flow · YoY (vs a year ago)
Free cash flow · YoY (vs a year ago)
| US$ | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | $6.76B | $7.60B | $9.23B | $8.96B | $8.52B | $9.43B | $10.51B | $12.64B |
| Capital spending | $-3.57B | $-4.16B | $-2.84B | $-3.58B | $-4.40B | $-4.74B | $-4.88B | $-4.94B |
| Free cash flow | $3.19B | $3.44B | $6.40B | $5.38B | $4.13B | $4.69B | $5.64B | $7.69B |
| FCF margin | 6.8% | 6.7% | 12.4% | 9.2% | 6.9% | 7.2% | 8.0% | 10.2% |
| Stock-based pay | $268.00M | $347.00M | $362.00M | $440.00M | $341.00M | $262.00M | $360.00M | $401.00M |
| Cash from investing | $-3.90B | $-5.72B | $-3.39B | $-2.64B | $-3.39B | $-5.32B | $-4.93B | $-4.99B |
| Cash from financing | $-3.08B | $-1.77B | $-4.68B | $-6.66B | $-5.66B | $-4.09B | $-4.58B | $-8.55B |
| Dividends paid | $-487.00M | $-550.00M | $-153.00M | $-624.00M | $-653.00M | $-661.00M | $-690.00M | $-679.00M |
| Share buybacks | $-1.53B | $-1.03B | $-441.00M | $-8.22B | $-7.00B | $-3.81B | $-6.04B | $-10.07B |
About
About HCA Healthcare Inc
HCA Healthcare, Inc. is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.
From Wikipedia (CC BY-SA 4.0).
Company details
- Company name
- HCA Healthcare Inc
- Ticker
- HCA
- Exchange
- NYSE
- ISIN
- US40412C1018
- SEC CIK
- 0000860730
- Sector
- Healthcare
- Industry
- Hospital/Nursing Management
- SEC industry (SIC)
- Services-general Medical & Surgical Hospitals, Nec (8062)
- Financial year ends
- 31 December
- Filer type
- Large accelerated filer
- Latest annual report (10-K)
- 10 Feb 2026
- CEO
- Samuel N. Hazen
- Chair
- Thomas F. Frist III
- Headquarters
- Nashville
- Address
- One Park Plz, Nashville, Tn 37203
- Founded
- 1968
- Employees
- 320,000
- Formerly known as
- Hca Holdings, Inc., Hca Inc/tn
- Trades in
- US dollars (USD)
- Website
- hcahealthcare.com
News
Latest news
From Google News; each link opens the publisher's story.
Peers
Others in Healthcare
Quotes from CNBC (may be delayed), financials from SEC EDGAR, profile from global-stock-logos (MIT). Information only, not investment advice.